De novo repeat interruptions are associated with reduced somatic instability and mild or absent clinical features in myotonic dystrophy type 1

Article metrics

Abstract

Myotonic dystrophy type 1 (DM1) is a multisystem disorder, caused by expansion of a CTG trinucleotide repeat in the 3′-untranslated region of the DMPK gene. The repeat expansion is somatically unstable and tends to increase in length with time, contributing to disease progression. In some individuals, the repeat array is interrupted by variant repeats such as CCG and CGG, stabilising the expansion and often leading to milder symptoms. We have characterised three families, each including one person with variant repeats that had arisen de novo on paternal transmission of the repeat expansion. Two individuals were identified for screening due to an unusual result in the laboratory diagnostic test, and the third due to exceptionally mild symptoms. The presence of variant repeats in all three expanded alleles was confirmed by restriction digestion of small pool PCR products, and allele structures were determined by PacBio sequencing. Each was different, but all contained CCG repeats close to the 3′-end of the repeat expansion. All other family members had inherited pure CTG repeats. The variant repeat-containing alleles were more stable in the blood than pure alleles of similar length, which may in part account for the mild symptoms observed in all three individuals. This emphasises the importance of somatic instability as a disease mechanism in DM1. Further, since patients with variant repeats may have unusually mild symptoms, identification of these individuals has important implications for genetic counselling and for patient stratification in DM1 clinical trials.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. 1.

    Turner C, Hilton-Jones D. Myotonic dystrophy: diagnosis, management and new therapies. Curr Opin Neurol. 2014;27:599–606.

  2. 2.

    Brook JD, McCurrach ME, Harley HG, et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell. 1992;68:799–808.

  3. 3.

    Mahadevan MS, Amemiya C, Jansen G, et al. Structure and genomic sequence of the myotonic dystrophy (DM kinase) gene. Hum Mol Genet. 1993;2:299–304.

  4. 4.

    Fu YH, Pizzuti A, Fenwick RG Jr., et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science. 1992;255:1256–8.

  5. 5.

    Jaspert A, Fahsold R, Grehl H, Claus D. Myotonic dystrophy: correlation of clinical symptoms with the size of the CTG trinucleotide repeat. J Neurol. 1995;242:99–104.

  6. 6.

    Harley HG, Rundle SA, MacMillan JC, et al. Size of the unstable CTG repeat sequence in relation to phenotype and parental transmission in myotonic dystrophy. Am J Hum Genet. 1993;52:1164–74.

  7. 7.

    Hunter A, Tsilfidis C, Mettler G, et al. The correlation of age of onset with CTG trinucleotide repeat amplification in myotonic dystrophy. J Med Genet. 1992;29:774–9.

  8. 8.

    Harley HG, Rundle SA, Reardon W, et al. Unstable DNA sequence in myotonic dystrophy. Lancet. 1992;339:1125–8.

  9. 9.

    Wong LJ, Ashizawa T, Monckton DG, Caskey CT, Richards CS. Somatic heterogeneity of the CTG repeat in myotonic dystrophy is age and size dependent. Am J Hum Genet. 1995;56:114–22.

  10. 10.

    Higham CF, Morales F, Cobbold CA, Haydon DT, Monckton DG. High levels of somatic DNA diversity at the myotonic dystrophy type 1 locus are driven by ultra-frequent expansion and contraction mutations. Hum Mol Genet. 2012;21:2450–63.

  11. 11.

    Morales F, Couto JM, Higham CF, et al. Somatic instability of the expanded CTG triplet repeat in myotonic dystrophy type 1 is a heritable quantitative trait and modifier of disease severity. Hum Mol Genet. 2012;21:3558–67.

  12. 12.

    Musova Z, Mazanec R, Krepelova A, et al. Highly unstable sequence interruptions of the CTG repeat in the myotonic dystrophy gene. Am J Med Genet A. 2009;149A:1365–74.

  13. 13.

    Braida C, Stefanatos RK, Adam B, et al. Variant CCG and GGC repeats within the CTG expansion dramatically modify mutational dynamics and likely contribute toward unusual symptoms in some myotonic dystrophy type 1 patients. Hum Mol Genet. 2010;19:1399–412.

  14. 14.

    Santoro M, Masciullo M, Pietrobono R, et al. Molecular, clinical, and muscle studies in myotonic dystrophy type 1 (DM1) associated with novel variant CCG expansions. J Neurol. 2013;260:1245–57.

  15. 15.

    Pesovic J, Peric S, Brkusanin M, et al. Molecular genetic and clinical characterization of myotonic dystrophy type 1 patients carrying variant repeats within DMPK expansions. Neurogenetics. 2017;18:207–18.

  16. 16.

    Warner JP, Barron LH, Goudie D, et al. A general method for the detection of large CAG repeat expansions by fluorescent PCR. J Med Genet. 1996;33:1022–6.

  17. 17.

    Kamsteeg EJ, Kress W, Catalli C, et al. Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2. Eur J Hum Genet. 2012;20:1203–8.

  18. 18.

    Gomes-Pereira M, Bidichandani SI, Monckton DG. Analysis of unstable triplet repeats using small-pool polymerase chain reaction. Methods Mol Biol. 2004;277:61–76.

  19. 19.

    Monckton DG, Wong LJ, Ashizawa T, Caskey CT. Somatic mosaicism, germline expansions, germline reversions and intergenerational reductions in myotonic dystrophy males: small pool PCR analyses. Hum Mol Genet. 1995;4:1–8.

  20. 20.

    Eid J, Fehr A, Gray J, et al. Real-time DNA sequencing from single polymerase molecules. Science. 2009;323:133–8.

  21. 21.

    Travers KJ, Chin CS, Rank DR, Eid JS, Turner SW. A flexible and efficient template format for circular consensus sequencing and SNP detection. Nucleic Acids Res. 2010;38:e159.

  22. 22.

    Giardine B, Riemer C, Hardison RC, et al. Galaxy: a platform for interactive large-scale genome analysis. Genome Res. 2005;15:1451–5.

  23. 23.

    Afgan E, Baker D, van den Beek M, et al. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2016 update. Nucleic Acids Res. 2016;44:W3–W10.

  24. 24.

    Girardot C, Scholtalbers J, Sauer S, Su SY, Furlong EE. Je, a versatile suite to handle multiplexed NGS libraries with unique molecular identifiers. BMC Bioinf. 2016;17:419.

  25. 25.

    Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25:1754–60.

  26. 26.

    Li H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM.arXiv:1303.3997 [q-bio.GN].

  27. 27.

    Milne I, Stephen G, Bayer M, et al. Using tablet for visual exploration of second-generation sequencing data. Brief Bioinform. 2013;14:193–202.

  28. 28.

    Dryland PA, Doherty E, Love JM, Love DR. Simple repeat-primed PCR analysis of the myotonic dystrophy type 1 gene in a clinical diagnostics environment. J Neurodegener Dis. 2013;2013:857564.

  29. 29.

    Botta A, Rossi G, Marcaurelio M, et al. Identification and characterization of 5′ CCG interruptions in complex DMPK expanded alleles. Eur J Hum Genet. 2017;25:257–61.

  30. 30.

    Loomis EW, Eid JS, Peluso P, et al. Sequencing the unsequenceable: expanded CGG-repeat alleles of the fragile X gene. Genome Res. 2013;23:121–8.

  31. 31.

    Landrian I, McFarland KN, Liu J, et al. Inheritance patterns of ATCCT repeat interruptions in spinocerebellar ataxia type 10 (SCA10) expansions. PLoS ONE. 2017;12:e0175958.

  32. 32.

    Schule B, McFarland KN, Lee K, et al. Parkinson’s disease associated with pure ATXN10 repeat expansion. NPJ Park Dis. 2017;3:27.

  33. 33.

    Doi K, Monjo T, Hoang PH, et al. Rapid detection of expanded short tandem repeats in personal genomics using hybrid sequencing. Bioinformatics. 2014;30:815–22.

  34. 34.

    Anvret M, Ahlberg G, Grandell U, et al. Larger expansions of the CTG repeat in muscle compared to lymphocytes from patients with myotonic dystrophy. Hum Mol Genet. 1993;2:1397–400.

  35. 35.

    Jinnai K, Mitani M, Futamura N, et al. Somatic instability of CTG repeats in the cerebellum of myotonic dystrophy type 1. Muscle Nerve. 2013;48:105–8.

  36. 36.

    Zhao XN, Usdin K. The repeat expansion diseases: the dark side of DNA repair. DNA Repair. 2015;32:96–105.

  37. 37.

    Morales F, Vasquez M, Santamaria C, et al. A polymorphism in the MSH3 mismatch repair gene is associated with the levels of somatic instability of the expanded CTG repeat in the blood DNA of myotonic dystrophy type 1 patients. DNA Repair. 2016;40:57–66.

  38. 38.

    Pearson CE, Nichol Edamura K, Cleary JD. Repeat instability: mechanisms of dynamic mutations. Nat Rev Genet. 2005;6:729–42.

  39. 39.

    Choudhry S, Mukerji M, Srivastava AK, Jain S, Brahmachari SK. CAG repeat instability at SCA2 locus: anchoring CAA interruptions and linked single nucleotide polymorphisms. Hum Mol Genet. 2001;10:2437–46.

  40. 40.

    Pearson CE, Eichler EE, Lorenzetti D, et al. Interruptions in the triplet repeats of SCA1 and FRAXA reduce the propensity and complexity of slipped strand DNA (S-DNA) formation. Biochemistry. 1998;37:2701–8.

  41. 41.

    Koch KS, Leffert HL. Giant hairpins formed by CUG repeats in myotonic dystrophy messenger RNAs might sterically block RNA export through nuclear pores. J Theor Biol. 1998;192:505–14.

  42. 42.

    Pettersson OJ, Aagaard L, Jensen TG, Damgaard CK. Molecular mechanisms in DM1 - a focus on foci. Nucleic Acids Res. 2015;43:2433–41.

  43. 43.

    Santoro M, Fontana L, Masciullo M, et al. Expansion size and presence of CCG/CTC/CGG sequence interruptions in the expanded CTG array are independently associated to hypermethylation at the DMPK locus in myotonic dystrophy type 1 (DM1). Biochim Biophys Acta. 2015;1852:2645–52.

  44. 44.

    Rahbari R, Wuster A, Lindsay SJ, et al. Timing, rates and spectra of human germline mutation. Nat Genet. 2016;48:126–33.

  45. 45.

    Pearson CE, Sinden RR. Alternative structures in duplex DNA formed within the trinucleotide repeats of the myotonic dystrophy and fragile X loci. Biochemistry. 1996;35:5041–53.

  46. 46.

    Gomes-Pereira M, Monckton DG. Ethidium bromide modifies the agarose electrophoretic mobility of CAG•CTG alternative DNA structures generated by PCR. Front Cell Neurosci. 2017;11:153.

Download references

Acknowledgements

We thank all participants in the DMGV study for their co-operation, in particular the members of the three families described here. Electromyography in patient DMGV182 was undertaken by Dr. Gregory Moran, Department of Clinical Neurophysiology, Western General Hospital, Edinburgh. Acknowledgement of grant support: Muscular Dystrophy Association (252524); Wellcome Trust Institutional Strategic Support Fund (ISSF) (097821/Z/11/Z); Muscular Dystrophy UK (formerly Muscular Dystrophy Campaign) (MC3/1073); Chief Scientist Office (CAF/MD/15/01).

The Scottish Myotonic Dystrophy Consortium

Cheryl Longman, Douglas Wilcox, Alison Wilcox, Richard Petty, Yvonne Robb, Maria Elena Farrugia, Helen Gregory, Alexis Duncan, Catherine McWilliam, John Dean, Anne-Marie Taylor, Lorna MacLeish, Monika Rahman, Anne McKeown, Kirsten Patterson, Mark Hamilton, Bob Ballantyne, Sarah Cumming and Darren G Monckton.

The Scottish Myotonic Dystrophy Consortium is a subgroup of the Scottish Muscle Network; Programme Manager Hugh Kennedy, Programme Support Officer Laura Craig.

Author information

Correspondence to Mark J. Hamilton.

Ethics declarations

Conflict of interest

Professor Monckton has been a paid scientific consultant of Biogen Idec, AMO Pharma, Charles River and Vertex Pharmaceuticals. Professor Monckton also has a research contract with AMO Pharma.

Electronic supplementary material

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Further reading